Clinical trial

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes

NCT01455857

View saved research
StatusCOMPLETED
Study typeINTERVENTIONAL
Start date2013-03-01
PhasePHASE3

Study timeline

Study start (unknown)2013-03-01Date precision: month
Registry last updated2015-08-18
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

What this registered study describes

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes is a interventional study listed under registry identifier NCT01455857. Its last published status is COMPLETED. Registry status does not establish that enrollment is currently open at every study site.

The published record lists 1 condition label(s), 2 intervention label(s), and 1 sponsor/collaborator entry or entries. The structured information below allows these links to be examined individually; intervention registration is not an efficacy claim.

Source: the original ClinicalTrials.gov study record. Always check the protocol, eligibility, dates, results (when posted), and contacts at the original source.

Mapped research locations

MiamiFlorida, United States5HoustonTexas, United States3ChicagoIllinois, United States3JacksonvilleFlorida, United States3DallasTexas, United States2San AntonioTexas, United States2CincinnatiOhio, United States2AustinTexas, United States2CharlotteNorth Carolina, United States2Colorado SpringsColorado, United States2Los AngelesCalifornia, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1BirminghamAlabama, United States1ColumbusOhio, United States1TampaFlorida, United States1DurhamNorth Carolina, United States1PhoenixArizona, United States1OrlandoFlorida, United States1Oklahoma CityOklahoma, United States1Las VegasNevada, United States1RichmondVirginia, United States1Winston-SalemNorth Carolina, United States1New OrleansLouisiana, United States1MemphisTennessee, United States1Little RockArkansas, United States1Kansas CityMissouri, United States1Long BeachCalifornia, United States1SpokaneWashington, United States1Fort WorthTexas, United States1BrooklynNew York, United States1KnoxvilleTennessee, United States1NorfolkVirginia, United States1FresnoCalifornia, United States1ToledoOhio, United States1HollywoodFlorida, United States1Walnut CreekCalifornia, United States1LincolnNebraska, United States1ClearwaterFlorida, United States1GreensboroNorth Carolina, United States1Boca RatonFlorida, United States1BillingsMontana, United States1Des MoinesIowa, United States1WilmingtonNorth Carolina, United States1Staten IslandNew York, United States1GreerSouth Carolina, United States1San JoseCalifornia, United States1HuntsvilleAlabama, United States1Pembroke PinesFlorida, United States1Toms RiverNew Jersey, United States1RentonWashington, United States1BradentonFlorida, United States1Sugar LandTexas, United States1EvansvilleIndiana, United States1Chula VistaCalifornia, United States1Coral GablesFlorida, United States1TustinCalifornia, United States1MetairieLouisiana, United States1

Clinical trial site map

Published registry research cities for this specific study. Pins represent city-level locations, not exact facility addresses. Confirm current enrollment and facility details with the study team.

58 published city locations shown (maximum 300). Some registry locations may not have coordinates or may not be published yet.

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.